In vitro microbiome and ex vivo intestinal models for gut health

Annika van Rosmalen is a Business Development Manager in the field of Pharma & Digital Health. She develops value propositions and strategic collaborations focused on patient‑generated data, real‑world data, digital biomarkers and patient‑centric digital trials. She connects partners to accelerate innovation in digital health.

The central aspect of my research is to better understand the interactions between the human body and the microbiome. By developing and applying in vitro model systems, these interactions can be explored in high detail.

In my research within the chair of Oral Systems Biology, I strive to unravel the intricate interactions between microbial communities and host physiology in the oral cavity and respiratory tract. By bridging the gap between fundamental science and applications, I hope to develop innovative strategies for preventing and treating oral diseases.

I am interested in the role that the human microbiome, particularly the gut microbiome, plays in human health and disease. The emphasis in my research is on finding ways to keep a healthy microbiome healthy and to get a disturbed microbiome healthy again. Dietary fibers and other natural ingredients play a major role in this research.

UMC Utrecht and TNO collaborate in research on food-borne risk factors for allergic and inflammatory diseases. We develop and apply methods to identify, characterize and manage food-borne risk factors that influence the inflammatory state of our body.